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Biological membrane fusion is dependent on protein catalysts to mediate the lipid rearrangements required for membrane merger (1, 2). The fusion-associated small transmembrane (FAST) proteins are one such family of membrane fusion
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catalysts (3). The FAST proteins are a unique group of small
(95–140 amino acids) integral membrane proteins encoded by
the fusogenic reoviruses, an unusual group of non-enveloped
viruses that induce syncytium formation (3– 6). Three distinct
members of the FAST protein family have been described in
recent years: the homologous p10 proteins of avian reovirus
and Nelson Bay reovirus and the unrelated p14 and p15 proteins of reptilian reovirus and baboon reovirus, respectively
(3–5). Unlike the well characterized fusion proteins of enveloped viruses (7), the FAST proteins are nonstructural viral proteins and are therefore not involved in viral entry into cells.
Following their expression inside virus-infected or -transfected
cells, the FAST proteins traffic through the endoplasmic reticulum-Golgi pathway to assume a bitopic Nexoplasmic/Ccytoplasmic
topology in the plasma membrane, where they mediate fusion
of virus-infected cells to neighboring uninfected cells (8 –10).
Therefore, the FAST proteins function more as “cellular” rather
than viral fusion proteins, mediating cell-cell rather than viruscell membrane fusion. Furthermore, a recent study using the
purified p14 FAST protein of reptilian reovirus reconstituted
into artificial lipid bilayers indicated that the FAST proteins are
both necessary and sufficient to mediate membrane fusion (11).
In addition to their unique role in the viral replication cycle,
the FAST proteins are also structurally distinct from enveloped
viral fusion proteins. In particular, at only ⬃22– 44 residues in
size, the FAST protein ectodomains are considerably less complex than the ectodomains of enveloped viral fusion proteins.
Current models propose that extensive structural remodeling
of the large metastable enveloped viral fusion protein ectodomains provides the energy required to drive the fusion reaction
(1, 12–15). Because the biophysical features of the FAST proteins are incompatible with a fusion mechanism dependent
on dramatic conformational changes in structurally complex
ectodomains, alternative models of protein-mediated membrane fusion must be considered. In the case of the 125-residue
p14 FAST protein, structural motifs relevant to the membrane
fusion activity include the transmembrane domain, a fusion
peptide loop and myristate moiety in the 36-residue N-terminal
ectodomain, and a membrane-proximal polybasic region in the
68-residue endodomain (4, 9). We currently favor a model of
FAST protein-mediated membrane fusion whereby membrane-interactive structural motifs function from either side
of the membrane to disrupt the boundary water layer associated with lipid head groups and/or alter lipid packing,
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The reovirus fusion-associated small transmembrane (FAST)
proteins are a unique family of viral membrane fusion proteins.
These nonstructural viral proteins induce efficient cell-cell
rather than virus-cell membrane fusion. We analyzed the lipid
environment in which the reptilian reovirus p14 FAST protein
resides to determine the influence of the cell membrane on the
fusion activity of the FAST proteins. Topographical mapping of
the surface of fusogenic p14-containing liposomes by atomic
force microscopy under aqueous conditions revealed that p14
resides almost exclusively in thickened membrane microdomains. In transfected cells, p14 was found in both Lubrol WXand Triton X-100-resistant membrane complexes. Cholesterol
depletion of donor cell membranes led to preferential disruption of p14 association with Lubrol WX (but not Triton X-100)resistant membranes and decreased cell-cell fusion activity,
both of which were reversed upon subsequent cholesterol repletion. Furthermore, co-patching analysis by fluorescence microscopy indicated that p14 did not co-localize with classical lipidanchored raft markers. These data suggest that the p14 FAST
protein associates with heterogeneous membrane microdomains, a distinct subset of which is defined by cholesterol-dependent Lubrol WX resistance and which may be more relevant
to the membrane fusion process.

FAST Proteins and Membrane Microdomains

4

The abbreviations used are: DRM(s), detergent-resistant membrane(s);
PLAP, placental alkaline phosphatase; M␤CD, methyl-␤-cyclodextrin;
VSV-G, vesicular stomatitis virus G protein; cLPDS, complete lipoproteindeficient serum; HBSS, Hanks’ buffered saline solution; PBS, phosphatebuffered saline; AFM, atomic force microscopy; LRMs, Lubrol WX-resistant
membranes; TRM(s), Triton X-100-resistant membrane(s); GM1, ganglioside GM1.
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adverse effects on the membrane fusion reaction (31). However, theoretical and experimental evidence suggests that some
membrane fusion reactions may be mediated within ordered
lipid microdomains (32–34). Mechanistic models of membrane
fusion may therefore need to adapt to the involvement of liquid-ordered lipid bilayers as a component of the fusion process.
We are particularly interested in understanding how the
FAST proteins induce cell-cell fusion. Because the membrane
environment from which the FAST proteins mediate the fusion
reaction is the cell plasma membrane and in view of the potentially significant impact of the biophysical properties of plasma
membrane lipid microdomains on models of the membrane
fusion reaction, we determined whether this recently discovered novel family of membrane fusion proteins associates with
membrane microdomains. Based on both detergent and nondetergent approaches, our results indicate that the p14 FAST
protein associates with distinct membrane microdomains, a
subset of which may contain p14 molecules more directly
involved in the membrane fusion process.

EXPERIMENTAL PROCEDURES
Cells and Materials—The rabbit anti-p14 polyclonal antiserum and the maintenance of QM5 (quail fibroblast) cells was
as described previously (4). N-BP-2 cells are Chinese hamster
ovary cell derivatives deficient in cholesterol synthesis because
of a deletion in the site-2 protease that activates the sterol regulatory element-binding proteins (35). These cells were
obtained from N. Ridgway (Dalhousie University) and were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 5% fetal bovine serum and cholesterol as described previously (36). Anti-placental alkaline phosphatase (PLAP) and
anti-human transferrin receptor monoclonal antibodies were
purchased from Dako and Zymed Laboratories Inc., respectively. Horseradish peroxidase-conjugated goat anti-mouse
and goat anti-rabbit antibodies were obtained from Kirkegaard
& Perry Laboratories, Inc. Lubrol WX was purchased from
SERVA; all other detergents and cholesterol-depleting reagents
(methyl-␤-cyclodextrin (M␤CD)) were from Sigma. CellTracker dyes were from Molecular Probes.
Expression Plasmids—The authentic p14 and non-myristoylated p14-G2A expression plasmids were as described previously (4). Plasmid vectors expressing PLAP or the human transferrin receptor were generously provided by D. Brown (State
University of New York) and C. Parish (Cornell University),
respectively. A eukaryotic expression plasmid encoding the
vesicular stomatitis virus G protein (VSV-G; Indiana serotype)
was provided by P. Lee (Dalhousie University).
Transfection, Cell Staining, and Syncytial Indexing—QM5
quail cell fibroblasts were transfected with p14 expression plasmids using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. At various times post-transfection, cell monolayers were fixed and stained with Wright-Giemsa, and the syncytial index was determined by quantifying
the numbers of syncytial nuclei present in random microscopic
fields as described previously (4). Results are reported as the
means ⫾ S.E. of three separate experiments.
Cholesterol Depletion and Repletion—Membrane cholesterol
was depleted from p14-transfected QM5 cells prior to the onset
JOURNAL OF BIOLOGICAL CHEMISTRY
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thereby lowering the energy barriers that impede membrane
fusion (8 –11, 16).
The realignment of lipids during the membrane fusion process is believed to proceed through a series of sequential steps
involving merger of the outer leaflets of two closely apposed
membranes to form a stalk; formation of a hemifusion diaphragm; and then merger of the inner leaflets, leading to pore
formation and pore expansion (2, 13). The lipid rearrangements
required to achieve these steps are complex and are believed to
require the formation of different non-bilayer structures
involving negative membrane curvature, acyl chain tilt, and
altered lipid packing (13, 17). The liquid-disordered fluid state
of biological membranes makes it easy to envision how lipid
molecules could be rearranged to form such non-bilayer structures. In recent years, however, the concept of a biological
membrane as a fluid mosaic containing randomly dispersed
membrane proteins moving through a fluid lipid bilayer has
been supplanted by the realization that biological membranes
likely contain regions highly biased in both their lipid and protein composition (18). These lipid-based membrane microdomains, so-called “rafts,” are currently viewed as small dynamic
clusters of protein and lipid enriched in cholesterol and/or
sphingomyelin (19). The tight lipid packing promoted by cholesterol and the unsaturated acyl chains present in such membrane microdomains promotes the formation of a liquid-ordered state in model membranes, which may render these lipid
microdomains more resistant to detergent solubilization (18,
20). However, the complex interactions between detergents
and the lipids and proteins present in membranes make it
unclear as to whether the biochemical and biophysical properties of isolated detergent-resistant membranes (DRMs)4 accurately reflect the properties of membrane microdomains present in native membranes (21–23).
Regardless of the exact relationship between DRMs and
actual membrane microdomains, considerable detergentdependent and -independent analyses support the concept of
membrane microdomains with distinct lipid/protein compositions that may serve as organizational centers for numerous
proteins (19, 24, 25). In the case of enveloped viral fusion proteins (26), membrane microdomains generally serve as platforms either to concentrate viral glycoproteins in the cell membrane to facilitate viral assembly or to localize viral receptors
during the entry process (27–30). If membrane fusion proteins
do function from lipid microdomains, then the potential liquidordered state of these microdomains may need to be rationalized with the formation of non-bilayer structures that are considered to be essential for the fusion process. It is possible that
the fusion proteins migrate out of the microdomains into the
more fluid adjacent lipid bilayer during the fusion process, as
suggested for influenza virus hemagglutinin, where disruption
of membrane microdomains by cholesterol depletion has no

FAST Proteins and Membrane Microdomains
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(30.8%), 0.5 ml of 0.8 M (27.2%), 1 ml of 0.7 M (24%), and 1 ml of
0.1 M (3.4%) sucrose. Sucrose density gradients were subjected
to ultracentrifugation at 332,000 ⫻ g for 18 –20 h and then
harvested from the top in 0.5-ml aliquots. The percent sucrose
in each fraction was determined using a refractometer. Total
protein (0.1 ml of each sucrose fraction) was precipitated using
chloroform and methanol and fractionated by SDS-PAGE (15%
acrylamide), and proteins were detected by immunoblotting
using mouse anti-PLAP or anti-human transferrin receptor
monoclonal antibody (1:2000) or rabbit anti-p14 polyclonal
antibody (1:10,000) and horseradish peroxidase-conjugated
secondary antibody (1:2000 –5000). Proteins were visualized by
chemiluminescence (ECL, Amersham Biosciences) according
to the manufacturer’s instructions. The distribution of p14 in
the various sucrose fractions was quantified by analysis of
scanned Western blots using Scion Image software, and the
mean density of individual bands was determined from four to
five separate experiments. In some cases, transfected cells were
labeled for 1 h with 50 Ci/ml [3H]leucine prior to harvesting,
and sucrose fractions were analyzed by immunoprecipitation
and SDS-PAGE using rabbit anti-p14 polyclonal antibody as
described previously (4).
Fluorescent Heterotypic Cell-Cell Fusion Assays—Individual cell populations were labeled with the dye CellTracker
Orange CMTMR (5-(6)-(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine; 5 M) or CellTracker Blue CMAC
(7-amino-4-chloromethylcoumarin; 2 M) for 45 min at
37 °C in HBSS following the manufacturer’s instructions.
Labeled donor cells were transfected with p14 as described
above. At 2.5 h post-transfection, donor or target cells were
treated with M␤CD to deplete cholesterol. The non-depleted cell population was suspended in PBS/EDTA, mixed
with 200 l of fetal bovine serum, pelleted by centrifugation
at 700 ⫻ g for 5 min, resuspended in 100 l of PBS, mixed
with 400 l of cLPDS, and seeded on monolayers of the
labeled cholesterol-depleted cell population grown on coverslips. The two cell populations were incubated for 2 h,
washed with HBSS, fixed with methanol, mounted on glass
slides using fluorescent mounting medium (Dako), and visualized and photographed using a Zeiss Axiovert 200 fluorescence microscope. The relative number of syncytia per field
was determined by counting the number of syncytia in
20 –50 random fields using a ⫻40 objective.
Atomic Force Microscopy (AFM)—Liposomes or proteoliposomes containing purified p14 in the liposome membranes
were prepared exactly as described previously (11). Lipid formulations consisted of 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine), 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine, cholesterol, and sphingomyelin at 40:20:20:20 mol %.
The fusion activity of p14 present in liposome membranes was
confirmed by monitoring liposome-cell membrane fusion as
reported previously (11). Supported bilayers were formed by
allowing liposomes in 10 mM HEPES (pH 7.5) to attach and then
collapse onto freshly cleaved mica surfaces. Following deposition of the lipid bilayers onto the mica surface for at least 2 h at
room temperature, AFM images were recorded under aqueous
conditions using the contact mode at room temperature with a
Molecular Imaging microscope. Images were recorded in both
VOLUME 281 • NUMBER 42 • OCTOBER 20, 2006
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of syncytium formation, which commenced at 4 –5 h posttransfection, either by acutely treating cells for 30 min with
10 –20 mM M␤CD in serum-free medium or in medium containing 10% fetal bovine serum or 5% complete lipoproteindeficient serum (cLPDS) or by incubating cells in medium containing cLPDS and 2 mM M␤CD. Following the acute
cholesterol depletion treatments, the medium containing
M␤CD was replaced with complete serum-free medium or with
medium supplemented with 5% cLPDS, and cells were incubated for an additional 2– 4 h until extensive syncytium formation appeared in the untreated transfected cells. Cells were then
fixed, stained, and assessed for syncytium formation as
described above. To assess the ability of M␤CD to deplete
membrane cholesterol, cells were preloaded for 4 h with 5
Ci/ml [3H]cholesterol (ICN), washed with Hanks’ buffered
saline solution (HBSS), and treated with M␤CD under the conditions described above. The cell supernatant was removed; the
cell monolayers were lysed in 200 l of radioimmune precipitation assay buffer (50 mM Tris-HCl (pH 8), 150 mM NaCl, 1 mM
EDTA, 1% (v/v) Igepal (Sigma), 0.5% (w/v) sodium deoxycholate, and 0.1% (w/v) SDS); and the percent [3H]cholesterol
present in the cell lysate and supernatant was determined by
scintillation counting. For cholesterol repletion experiments,
cholesterol (6 mg/ml) was dissolved in 20 mM M␤CD in serumfree medium by vigorous vortexing and heating at 37 °C for 30
min, filtered to remove insoluble cholesterol, and added to cholesterol-depleted cells for 30 min at 37 °C. In some experiments,
the effects of cholesterol depletion on cell-cell fusion mediated
by p14 or VSV-G were examined using N-BP-2 cells (cholesterol auxotrophs). Cells were cultured for 12 h in Dulbecco’s
modified Eagle’s medium containing 5% cLPDS with or without
cholesterol supplementation as described previously (36). Cells
were transfected in the appropriate cholesterol-containing
serum-free medium, fixed at 12 h post-transfection (24 h postcholesterol depletion), Giemsa-stained, and assessed for the
extent of cell-cell fusion. Control experiments using fluorescence-activated cell sorter analysis and a green fluorescent protein expression vector indicated no difference in the transfection efficiency of the QM5 cells (63–72%) under the various
cholesterol conditions.
Detergent Extraction and Sucrose Density Gradient Centrifugation—10-cm dishes of subconfluent QM5 cells were transfected with p14. After 12–14 h, when syncytium formation was
extensive, cells were detached from the substratum with 50 mM
EDTA for 15 min; centrifuged at 500 ⫻ g; and resuspended in
0.5 ml of phosphate-buffered saline (PBS), radioimmune precipitation assay buffer, 0.5% (v/v) Triton X-100, 0.5% (w/v)
Lubrol WX (with or without 1 M NaCl), 60 mM octyl glucoside,
0.5% (v/v) Brij 56, or 0.5% (v/v) Brij 58. All detergents were
dissolved in 50 mM Tris-HCl (pH 8), 150 mM NaCl, and 1 mM
EDTA, and all lysis buffers contained protease inhibitors (200
nM aprotinin, 1 M leupeptin, and 1 M pepstatin (Sigma)).
When no detergent was used, cells were vesiculated by 20
passes through a 30-gauge needle, and unbroken cells and
debris were removed by centrifugation at 700 ⫻ g for 2 min;
when detergent-containing buffer was used, cells were lysed at
4 °C for 30 – 45 min. Cell lysates (250 l) were mixed with 250
l of 2.4 M (82.4%) sucrose and overlaid with 1 ml of 0.9 M
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RESULTS
p14-induced Membrane Fusion Is Sensitive to Donor Membrane Cholesterol Levels—In view of the importance of the lipid
environment to membrane fusion and the absence of any information on the effect of this environment on the function of the
recently discovered FAST proteins, we examined the influence
of cholesterol on syncytium formation induced by the p14
FAST protein. QM5 fibroblasts were transfected with a p14
expression plasmid, and membrane cholesterol was depleted
with M␤CD prior to the onset of cell-cell fusion. Quantitative
analysis indicated that M␤CD extracted 60 –90% of the membrane cholesterol under various extraction conditions (Fig. 1D)
and that p14-induced syncytium formation was inhibited by
80 –90% under all conditions (Fig. 1, A and B). Furthermore,
restoration of membrane cholesterol by treatment of cells with
cholesterol-loaded M␤CD substantially restored the rate of
syncytium formation (Fig. 1C). Accounting for the 60-min lag
between the time course of syncytium formation in treated
versus untreated cells (i.e. the time course of syncytium formation in treated cells was delayed by the cholesterol depletion and repletion steps), cholesterol repletion essentially
restored p14-induced syncytium formation to the levels
observed in untreated cells (data not shown).
To control for possible indirect effects of cholesterol depletion on p14-mediated cell-cell fusion, we examined the effects
of acute cholesterol depletion by M␤CD on the cell-cell fusion
activity of the VSV-G fusion protein. Although VSV-G does not
appear to associate with lipid microdomains based on detergent
fractionation analysis (29), the effects of cholesterol depletion
by M␤CD on VSV-G cell-cell fusion activity have never been
reported. To serve as a suitable control for p14 inhibition by
cholesterol depletion, rather than using low pH treatment to
trigger VSV-G fusion activity, we exploited the fact that transient overexpression of VSV-G in cells that partially acidify the
medium results in gradual cell-cell fusion. This phenotype parallels the progressive fusion activity of the FAST proteins,
which are untriggered fusogens. As shown in Fig. 1C, cell-cell
fusion mediated by VSV-G was completely unaffected by acute
cholesterol depletion conditions that inhibited p14 fusion
activity by ⬎80%.
We also examined p14 fusion activity in N-BP-2 cells, a cholesterol auxotrophic cell line (35). Under conditions in which
N-BP-2 cells are deficient in membrane cholesterol (24 h of
cholesterol depletion), p14-induced cell-cell fusion was inhibited by ⬃50% (Fig. 1C). However, the same experimental conditions resulted in ⬃70% inhibition of VSV-G cell-cell fusion
both when VSV-G fusion occurred under the neutral pH conditions described above (data not shown) and when fusion was
triggered by low pH treatment (Fig. 1C). The different effects of
the two cholesterol depletion protocols (i.e. M␤CD or auxotrophic cells) on VSV-G fusion activity most likely reflect differences in the cellular response to acute versus extended cholesterol depletion.
Because cholesterol depletion can exert its effect on membrane fusion proteins from either the donor or target membrane (30, 34, 40), we used a fluorescent heterotypic cell-cell
fusion assay and acute cholesterol depletion with M␤CD to
JOURNAL OF BIOLOGICAL CHEMISTRY
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height and deflection modes. V-shaped cantilevers with oxidesharpened Si3N4 tips (Veeco) were used with spring constants
of 0.01 newton-meter as specified by the manufacturer. High
resolution images were recorded with optimized feedback
parameters at scan frequencies of 4 Hz. Very low forces were
applied during the scan, and the threshold for imaging was estimated at ⬃400 piconewtons. Images were obtained from at
least three different samples prepared on different days, and
several macroscopically separate areas were scanned on each
sample. Several images were analyzed from each experiment,
and ⬃100 AFM cross-section profiles were used to estimate the
height of the observed membrane microdomains and p14 protein spikes (height of the microdomains ⫽ 0.8 ⫾ 0.2 nm (n ⫽
30) and height of the spikes ⫽ 1.5 ⫾ 0.5 nm (n ⫽ 70)).
Surface Fluorescence Microscopy and Co-localization—
QM5 cells grown on coverslips were transfected or cotransfected and stained for surface immunofluorescence. For
cotransfection experiments, the non-fusogenic p14 construct
(p14-G2A) was used to prevent syncytium formation and to
allow expression of PLAP. At 24 h post-transfection, cells were
preblocked with whole goat IgG (1:1000) in HBSS for 30 min at
4 °C, treated with primary antibody (rabbit anti-p14 polyclonal
antibody (1:200) and/or mouse anti-PLAP monoclonal antibody (1:50) in the blocking buffer) for 60 min at 4 °C, washed
with HBSS, and then treated with secondary antibody (Alexa
Fluor 488- or Alexa Fluor 555-conjugated goat anti-mouse
and/or goat anti-rabbit IgG (1:200; Molecular Probes) in the
blocking buffer). After secondary antibody addition and washing, cells were fixed with 3.7% formaldehyde in PBS and
mounted on glass slides using fluorescent mounting medium.
GM1 was stained using Alexa Fluor 555-conjugated cholera
toxin B (0.1 g/ml) during the primary antibody incubation.
After washing as described above, anti-cholera toxin B antibody
(1:200) was added during the secondary antibody incubation to
cause individual GM1 molecules on the cell surface to coalesce
(37). Stained cells were visualized and photographed using a
Zeiss LSM 510 META scanning argon laser confocal microscope and a ⫻100 objective.
Thin Layer Chromatography—Untransfected or p14-transfected QM5 cells were labeled with 10 Ci of [14C]acetate/dish
(107 cells) for 16 –18 h. After labeling, cells were left untreated
or treated with M␤CD for cholesterol depletion/repletion as
described above and extracted with Lubrol WX or Triton
X-100 prior to isolation of DRMs by sucrose density gradient
ultracentrifugation as described above. Total lipid from each
fraction or fraction pool was isolated using 2:1 (v/v) chloroform/methanol (38), and aliquots of the lipid extract containing
equal amounts of radioactivity (20,000 dpm) were applied to
Silica Gel G plates (Macherey-Nagel). Cholesterol and phospholipids were fractionated by thin layer chromatography
using a 24:30:6:30 (v/v/v/v) chloroform/ethanol/water/triethylamine mobile phase as described previously (39). Phospholipid/
cholesterol standards were run in parallel and detected by treatment with sulfuric acid and charring at 180 °C. The percentage
of radioactivity recovered in each lipid spot was quantified
using a Model GS-525 molecular imager system and Molecular
Analyst 1.5 software (Bio-Rad).

FAST Proteins and Membrane Microdomains

31782 JOURNAL OF BIOLOGICAL CHEMISTRY

VOLUME 281 • NUMBER 42 • OCTOBER 20, 2006

Downloaded from http://www.jbc.org/ by guest on January 28, 2020

FIGURE 1. p14-induced syncytium formation is influenced by membrane cholesterol in the donor membrane. A and B, p14-transfected
QM5 cells were left untreated or were treated, respectively, with 2 mM
M␤CD in medium containing 5% cLPDS just prior to and during syncytium
formation. Cells were Giemsa-stained and observed under a light microscope for the appearance of multinucleated syncytia. Arrows in A indicate
numerous syncytial foci. The arrow in B indicates a single small syncytium.
Scale bars ⫽ 100 m. C, QM5 cells transfected with the p14 or VSV-G
expression plasmid were treated for 30 min with 10 mM M␤CD (CD) just
prior to the onset of syncytium formation. A sample of p14-transfected,
M␤CD-treated QM5 cells was subsequently supplemented with exogenous cholesterol for 30 min at 37 °C using M␤CD-cholesterol complexes
(CDC). All cells were maintained in serum-free medium at 37 °C for an
additional 2– 4 h. Similar studies were performed in p14- or VSV-G-transfected N-BP-2 cells (NBP), except that cholesterol depletion was induced
by culturing these cholesterol auxotrophs under cholesterol-limiting conditions for 24 h as described under “Experimental Procedures.” At the completion of each experiment, cells were Giemsa-stained, and the average number
of nuclei present in syncytia was determined by microscopic examination of five
random fields and used to determine the percent fusion relative to untreated
cells. Results are expressed as the means ⫾ S.E. of three separate experiments,
except for the VSV-G results in N-BP-2 cells, which are the means ⫾ S.D. of a single
experiment. Results from the replicate experiments are provided in the supplemental material. D, p14-transfected QM5 cells were prelabeled with
[3H]cholesterol and then left untreated (UT ) or treated with 2 or 20 mM M␤CD
(2-CD and 20-CD, respectively) in serum-free medium (white bars), 5% cLPDS
(black bars), or 10% fetal bovine serum (gray bars). The percent [3H]cholesterol
extracted from the cells by M␤CD was quantified by scintillation counting. E,
untransfected QM5 cells prelabeled with CellTracker Blue CMAC (blue) were
co-cultured with p14-transfected cells prelabeled with CellTracker Orange
CMTMR (red). Fluorescence microscopy revealed the presence of syncytial
foci containing both red and blue cell nuclei, indicating that p14-transfected
donor cells fuse to untransfected target cells. Scale bar ⫽ 30 m. Arrows indicate the edges of a single syncytium. F, the same experiment as described for
E was conducted, except that p14-transfected donor cells or untransfected
target cells were treated with 0, 10, or 20 mM M␤CD prior to co-culturing the
two cell populations. The number of syncytial nuclei per field was determined
by counting random microscopic fields and used to calculate the percent
fusion relative to the untreated sample. Results are the means ⫾ S.E. of three
experiments.

examine the influence of donor versus target membrane cholesterol levels on p14-mediated cell-cell fusion. p14-transfected
cells (donor membranes) and untransfected cells (target membranes) were fluorescently labeled with different CellTracker
dyes, depleted of cholesterol using 10 or 20 mM M␤CD, and
then co-cultured and monitored for cell-cell fusion. Quantifying the formation of heterotypic syncytia (i.e. syncytia containing both donor (Fig. 1E, red) and target (blue) nuclei) revealed
that depletion of donor membrane cholesterol resulted in a
dose-dependent decrease in p14-induced syncytium formation
(⬎90% inhibition), whereas depletion of target membrane cholesterol had little, if any, significant effect on syncytium formation (Fig. 1F). The cell-cell fusion activity of p14 therefore
appears to be sensitive to the cholesterol content of the membrane in which p14 resides.
p14 Associates with Detergent-resistant Membranes in a Myristoylation-independent Manner—The donor membrane cholesterol dependence of p14-induced syncytium formation suggested that p14 might localize to cholesterol-rich membrane
microdomains. In accord with this possibility, a significant proportion of p14 remained detergent-insoluble when cells were
extracted with the non-ionic detergents Triton X-100, Lubrol
WX, Brij 56, and Brij 58 (Fig. 2A). Qualitative assessments indicated that p14 exhibited differential resistance to solubilization
by the different detergents, with the greatest proportion of
insoluble p14 observed following Lubrol WX extraction. The
inclusion of high salt in the lysis buffer did not disrupt the
Lubrol WX-insoluble nature of p14, whereas treatment of cells
with octyl glucoside, which tends to preserve cytoskeleton-associated membrane proteins but solubilizes membrane
microdomains (41, 42), rendered p14 completely soluble (Fig.
2A), suggesting that p14 association with DRMs is not due to
residual cytoskeletal interactions.
Sucrose density gradient centrifugation confirmed the association of p14 with DRMs as evidenced by the migration of a
proportion of the Triton X-100- and Lubrol WX-insoluble p14
to the low density 10 –20% sucrose fractions (Fig. 2B). The presence of p14 in DRMs was not due to inadequate detergent/lipid
or detergent/protein ratios required to efficiently solubilize
membranes, as indicated by the complete solubilization by
Lubrol WX of the transferrin receptor, an archetypal membrane protein that does not associate with DRMs (Fig. 2B). In
contrast to PLAP, a glycophosphatidylinositol-linked microdomain-associated protein which localized exclusively to the low
density DRM sucrose fractions, p14 exhibited a broad and
somewhat variable (e.g. compare Figs. 2B and 3) density distribution following extraction with either Triton X-100 or Lubrol
WX, a profile similar to that of numerous other microdomainassociated transmembrane proteins (43– 46). Quantitative
analysis of p14 distribution in the sucrose density fractions
based on pixel analysis of the fluorograms from four to five
individual experiments indicated that, on average, approximately half of the total p14 present in detergent cell lysates was
associated with DRMs, with the remainder distributed
throughout the intermediate and high density sucrose fractions
(Fig. 2C). The fact that Lubrol WX solubilized more p14 compared with Triton X-100 (i.e. 38 and 20% of p14 were found in
the soluble high density sucrose fractions following extraction
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FIGURE 3. p14 association with DRMs is myristoylation-independent.
QM5 cells transfected with authentic p14 (b and d) or non-myristoylated p14G2A (a and c) were lysed with either Triton X-100 (a and b) or Lubrol WX (c and
d) and subjected to sucrose density gradient ultracentrifugation. Sucrose
fractions were analyzed for the presence of p14 by SDS-PAGE and immunoblotting with anti-p14 polyclonal antibody. The percent sucrose in each fraction of the gradient is indicated below the corresponding panel. inter, intermediate density sucrose fraction.

with Lubrol WX and Triton X-100, respectively) argues against
the concern that Lubrol WX is a less efficient detergent than
Triton X-100 and therefore not useful for identifying microdomain-associated proteins (47). Both the detergent resistance
and cholesterol sensitivity of p14 were suggestive of p14 association with membrane microdomains.
Because myristate can serve as a targeting signal for membrane microdomains (41), the demonstration that p14 associates with DRMs provided a possible explanation for the
essential role of N-terminal myristoylation in the fusion
activity of p14 (4). However, analysis of a previously characterized non-myristoylated construct of p14, p14-G2A (9),
indicated that this was not the case; aside from slight variations between experiments in the relative distribution of p14
in the low and intermediate density sucrose fractions, the
OCTOBER 20, 2006 • VOLUME 281 • NUMBER 42
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FIGURE 2. p14 associates with both Lubrol WX- and Triton X-100-resistant
membranes. A, radiolabeled p14-transfected QM5 cells were treated with
PBS, radioimmune precipitation assay (RIPA) buffer, 0.5% Triton X-100 (TX),
0.5% Lubrol WX (LB), 0.5% Lubrol WX in 1 M NaCl (LB/salt), 60 mM octyl glucoside (OG), 0.5% Brij 56, or 0.5% Brij 58 on ice for 45 min. Cell extracts were
fractionated into soluble (S) and insoluble membrane (M) fractions by ultracentrifugation, and the presence of p14 in each fraction was detected by
immunoprecipitation, SDS-PAGE, and fluorography. B, p14-, PLAP-, or human
transferrin receptor (TfR)-transfected QM5 cells were lysed with either 0.5%
Triton X-100 (left panels) or 0.5% Lubrol WX (right panels) and subjected to
sucrose density gradient ultracentrifugation. Sucrose fractions were analyzed
for the presence of protein by SDS-PAGE and immunoblotting with anti-p14,
anti-PLAP, or anti-human transferrin receptor antibody. The percent sucrose
present in each fraction of the gradient is indicated below the corresponding
panel. C, the percentage of total p14 protein present in the pooled raft, intermediate (inter), and soluble fractions from sucrose gradients similar to those
in B was quantified using Scion Image software, and results are presented as
the means ⫾ S.E. of four to five separate experiments.

p14-G2A construct displayed the same general distribution
in sucrose gradients as authentic p14 (Fig. 3). The p14 protein therefore associates with DRMs (and by inference,
membrane microdomains in cells) in a myristoylation-independent manner.
Preferential Association of p14 with Lipid Microdomains—
Although detergent insolubility serves as the most common
operational definition of a microdomain-associated protein,
the uncertain nature of the relationship between DRMs and
functional membrane microdomains complicates this simple
interpretation (19, 21–23). Detergent-independent evidence
for p14 association with lipid microdomains was therefore
obtained by AFM using supported lipid bilayers containing p14.
Following deposition of lipid vesicles onto mica surfaces, the
liposomes flatten and merge to form double bilayer discs that
subsequently rupture to form a continuous supported phospholipid bilayer (48). Such supported bilayers provide a platform for the analysis of membrane proteins under near-physiological conditions and have been used recently in conjunction
with AFM to study lipid microdomains and microdomain-associated proteins (49 –51). AFM is based on scanning the surface of mica-supported lipid bilayers using a sharpened Si3N4
probe attached to a flexible cantilever. Vertical deflections of
the probe are detected and used to map the surface contour of
the membrane at very high resolution (⬍1 nm) (52). We demonstrated recently that purified p14 reconstituted into 400 nm
liposomes composed of a model mixture of membrane lipids (1,
2-dioleoyl-sn-glycero-3-phosphatidylcholine/1,2-dioleoyl-snglycero-3-phosphatidylethanolamine/cholesterol/sphingomyelin
at 40:20:20:20 mol %) mediates efficient liposome-cell fusion, indicating that p14 in these liposomes resides in a fusion-competent
membrane environment (11). We therefore used these fusogenic
liposomes to generate supported lipid bilayers, and the surface
topography of the bilayers was examined by high resolution
AFM under aqueous conditions.
Membrane microdomains spontaneously formed in proteinfree lipid bilayers and were readily observed by AFM as discrete
patches of membrane extending ⬃0.8 ⫾ 0.2 nm above the lipid
bilayer (Fig. 4, A–C). The difference in height of the membrane
microdomains and surrounding lipid bilayer approximated the
difference in length between 1,2-dioleoyl-sn-glycero-3-phos-
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phatidylcholine and sphingomyelin molecules, suggesting that
these microdomains are enriched in sphingomyelin and likely
exist in a liquid-ordered phase. These results were in good
agreement with previous AFM reports on the spontaneous formation and thickness of cholesterol- and/or sphingomyelinrich lipid microdomains in supported lipid bilayers (49, 50, 53).
The lipid microdomains were heterogeneous in size, ranging
from ⬃50 to 500 nm in diameter, a size distribution that probably reflects lateral mobility and merger of smaller microdomains during the transition from liposomes to a supported
bilayer (50). Microdomains with similar two-dimensional proportions were observed in supported lipid bilayers that contained p14, although their surface topography was markedly
altered by the presence of numerous protrusions extending
above the height of the membrane microdomains (Fig. 4, D–F).
Such protrusions were never observed in the membranes of
protein-free liposomes, suggesting that they represent the p14
protein. When viewed from above, the protrusions were visible
in the shaded height projection as white spots (Fig. 4D). In
cross-sections, the protrusions projected ⬃1.5 ⫾ 0.5 nm above
the surface of the microdomains, which themselves extended
⬃0.8 nm above the lipid bilayer (Fig. 4E). When viewed in three
dimensions (Fig. 4F), the protrusions appeared as distinct
spikes, similar in appearance although smaller in height (i.e. 1.5
versus 10 nm) than the microdomain-associated spikes of the
much larger PLAP protein previously observed by AFM (49).
Most notable was the fact that the majority of the p14 protein
spikes were found associated with the thickened membrane
microdomain platforms. This is evident from the preferential
association of the white spots with the obvious microdomain
platforms in the lower magnification two-dimensional shaded
height projection (Fig. 4D) and by the clustering of the protein
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spikes in the higher magnification three-dimensional projection (Fig. 4F).
The high resolution of AFM revealed further complexity in
the surface topography of the p14-containing lipid microdomains. In addition to the increased variations in height conferred by the prominent 1.5-nm tall protein spikes, a second
series of what appeared to be shorter protrusions was observed
in the microdomains containing p14. The height of these
smaller projections averaged ⬃0.7 nm above the lipid microdomains (Fig. 4E). In the three-dimensional image, these smaller
protrusions imparted a more irregular surface to the p14-containing lipid microdomains (Fig. 4F). We suggest that these two
populations of protrusions most likely represent two topologies
of p14 in liposome membranes (both the correct N-exoplasmic/C-cytoplasmic and the inverse C-exoplasmic/N-cytoplasmic topology), as indicated previously by flow cytometry of
p14-containing liposomes using anti-p14 N and C termini-specific antisera (11). Support for this conjecture derives from the
⬃2-fold difference in the size of the p14 N-terminal ectodomain and C-terminal endodomain (i.e. 36 versus 68 residues),
which closely mirrors the 2-fold difference in the average
heights of the projections (i.e. 0.7 versus 1.5 nm). The AFM
results provide compelling detergent-independent evidence
that p14 preferentially associates with lipid microdomains
under aqueous conditions.
Distinct Populations of p14-containing Detergent-resistant
Membranes—Further analysis of the detergent solubility of p14
extracted from transfected cells unveiled two additional notable features of p14 association with DRMs. The first related to
the approximately equivalent percentages of p14 associated
with either Lubrol WX-resistant membranes (LRMs) or Triton
X-100-resistant membranes (TRMs) (Fig. 2, B and C). This
VOLUME 281 • NUMBER 42 • OCTOBER 20, 2006

Downloaded from http://www.jbc.org/ by guest on January 28, 2020

FIGURE 4. p14 associates with membrane microdomains under aqueous conditions. AFM images were obtained from supported lipid bilayers prepared
from liposomes either lacking (A–C ) or containing (D–F ) purified p14. The images in A and D were taken from above, and height projections were colormatched (lowest to highest corresponds to black to white). The black background represents the lipid bilayer; the gray regions correspond to raised lipid
microdomains; and the white spots in D correspond to protrusions projecting above the height of the lipid microdomains in the p14-containing bilayers. The
horizontal white lines in A and D indicate the AFM tracing used to obtain the corresponding virtual cross-section profiles of each AFM image presented in B and
E. The horizontal lines in B and E denote the height of the lipid microdomains above the lipid bilayers. Numbers indicate height differences (in nanometers) of
the indicated topographical features. The surface contours of the bilayers are presented in three-dimensions in C and F, showing the raised lipid microdomains
containing the protruding p14 protein spikes. Scale bars ⫽ 300-nm horizontal distance (C and F ).
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observation appeared to be at odds with previous studies suggesting that LRMs and TRMs contain distinct subpopulations
of membrane microdomains that differ both in their lipid composition and in the proteins that preferentially associate with
them (43– 45, 54). However, other proteins that associate with
both types of DRMs have been identified, suggesting that certain proteins may not be as restricted in their choice of compatible lipid environments (43, 46, 55). To determine whether this
latter case applies to p14, thin layer chromatography was used
to ascertain whether the DRMs isolated with the different
detergents were compositionally distinct. As shown in Fig. 5A,
LRMs isolated from quail cells contained slightly more cholesterol and sphingomyelin (27 versus 20% and 11 versus 9%,
respectively) and less phosphatidylcholine (35 versus 45%,
respectively) compared with TRMs, percentages that were reasonably consistent in two independent experiments. Furthermore, the relative lipid compositions of the DRMs obtained
from untransfected cells extracted by the two detergents were
similar to those observed in identical fractions obtained from
p14-transfected cells extracted in the same manner, particularly in regard to their cholesterol and sphingomyelin content
(Fig. 5B). Differences were noted in some of the more minor
lipid components (e.g. glucosylceramide). These results suggest
that the effect, if any, of p14 recruitment of a specific subset of
membrane lipids into DRMs is moderate and indicate that p14
can associate with biochemically distinct DRM environments.
This latter point does not imply that the different detergents
extract intact membrane microdomains, merely that p14 can
associate with distinct lipid environments.
OCTOBER 20, 2006 • VOLUME 281 • NUMBER 42

The second notable feature of p14 segregation between
detergent-soluble and -insoluble fractions became apparent
following analysis of the effects of cholesterol depletion/repletion on p14 resistance to detergent extraction. In four to five
separate experiments, cholesterol depletion led to an average
50% decrease in the proportion of p14 found in the LRMs and a
concomitant increase in the percentage of soluble p14 in the
high density sucrose fractions. Subsequent restoration of membrane cholesterol redistributed p14 back into the Lubrol WXresistant low density sucrose fractions (Fig. 6, B and C). Such
was not the case with TRMs; cholesterol depletion/repletion
had little, if any, effect on redistributing p14 between the soluble and TRM fractions (Fig. 6, A and C). The same situation
applied to PLAP (i.e. cholesterol-dependent association with
LRMs, but not TRMs) and has been previously noted for the
association of PLAP and other membrane proteins with TRMs
(56 –58). We noted that the differential effect of cholesterol
depletion/repletion on p14 association with LRMs (but not
TRMs) correlated both with the increased cholesterol content
of LRMs (Fig. 5) and with the inhibitory effects of cholesterol
depletion on p14-induced cell-cell fusion (Fig. 1C). The cholesterol depletion/repletion studies indicated that p14 associates
with biochemically distinct subsets of membrane microdomains, one or more of which are partially resistant to Lubrol
WX extraction and which may contain a subpopulation of p14
actively involved in the cell-cell fusion process.
Further detergent-independent evidence that p14 associates with heterogeneous membrane microdomains was
obtained by fluorescence microscopy. Patching of surfaceJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 5. Lipid profiles of LRMs and TRMs. A, untransfected QM5 cells were radiolabeled with [14C]acetate. After sucrose density gradient ultracentrifugation
of Lubrol WX (L)- or Triton X-100 (T)-extracted membranes, the low density DRM fractions (fractions 2– 4) were pooled, and total lipids were fractionated by thin
layer chromatography and detected by fluorography. Each lipid was identified by comparison with known standards that were run in parallel. The amount of
radioactivity corresponding to each lipid was quantified and is displayed in the corresponding table. Values are reported for two independent experiments,
along with the average (boldface). NLs, neutral lipids; chol, cholesterol; Glu-cer: glucosylceramide; Gal-cer, galactosylceramide; ?, unidentified phospholipid; PE,
phosphatidylethanolamine; PI, phosphatidylinositol; PS/Lac-cer, phosphatidylserine/lactosylceramide; PC, phosphatidylcholine; Sph, sphingomyelin. B,
untransfected (⫺) or p14-transfected (⫹) QM5 cells were radiolabeled with [14C]acetate, lysed with either Lubrol WX (Lub) or Triton X-100 (TX), and fractionated
by sucrose density gradient ultracentrifugation. The lipid contents of the DRM fractions were analyzed by thin layer chromatography as described for A. The
amount of radioactivity corresponding to each lipid was quantified and is displayed in the corresponding table. Values are reported for a single experiment.
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FIGURE 6. p14-containing LRMs are sensitive to cholesterol depletion. A
and B, p14- or PLAP-transfected QM5 cells were lysed with either Triton X-100
or Lubrol WX, respectively. After sucrose density gradient ultracentrifugation,
fractions of each gradient were analyzed for the presence of protein by SDSPAGE and immunoblotting with anti-p14 polyclonal or anti-PLAP monoclonal
antibody. In each experiment, prior to detergent extraction, cells were either
left untreated ((⫺)CD) or were treated with 20 mM M␤CD ((⫹)CD) or with
M␤CD followed immediately by cholesterol repletion using M␤CD-cholesterol complexes ((⫹)CDC). The percent sucrose in each fraction of the gradient is indicated below the corresponding panel. inter, intermediate density
sucrose fraction. C, the percentage of total p14 protein in pooled fractions
from sucrose gradients similar to those in A and B was quantified using Scion
Image software. Fractions 2– 4, low density DRM fractions; fractions 5– 6, intermediate density fractions; fractions 7– 8, soluble high density fractions.
Results are displayed graphically and represent the means ⫾ S.E. of four
to five separate experiments. MBCD, M␤CD; MBCD⫹C, M␤CD-cholesterol
complexes.

expressed p14 with anti-p14 polyclonal antiserum prior to
fixation did not result in obvious co-localization with the
glycophosphatidylinositol-linked protein PLAP, similarly
clustered using anti-PLAP antibody, or with the sphingolipid
GM1, clustered using subunit B of cholera toxin and anticholera toxin antibody (Fig. 7). Aside from a very low level of
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co-localization, one might expect, on a purely random basis,
the majority of p14 to appear in clusters that do not overlap
with patches containing either PLAP or GM1, suggesting
that p14 associates with subsets of membrane microdomains
that may be distinct from those containing certain classical
raft markers. Interestingly, although PLAP and GM1 have
been reported to co-patch in T cells (37), they did not colocalize following patching in QM5 cells (Fig. 7, g–i). A similar lack of co-patching of microdomain-associated proteins
has been noted in other systems (59, 60), results consistent
with the emerging view that membrane microdomains are
most likely heterogeneous, small, and dynamic structures.
Consequently, proteins that transiently associate with the
same microdomain would not necessarily co-patch following antibody-mediated clustering. Alternative approaches
such as fluorescence resonance energy transfer might
address whether p14 transiently associates with other
microdomain-associated proteins.

DISCUSSION
Biochemical, microscopic, and morphological analyses support the concept that p14 preferentially associates with membrane microdomains with features (i.e. sensitivity to cholesterol
depletion and detergent insolubility) that are consistent with
cholesterol- and/or sphingolipid-enriched microdomains. The
AFM results also indicated that p14 can associate, at least in
model membranes, with lipid microdomains that likely exist in
a liquid-ordered phase. The association of p14 with membrane
VOLUME 281 • NUMBER 42 • OCTOBER 20, 2006
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FIGURE 7. p14 does not co-localize with classical raft markers. In a– c,
cells were cotransfected with PLAP and the non-fusogenic p14-G2A construct so as to prevent syncytium formation and to allow sufficient time for
PLAP expression. Unfixed cells were surface-stained using anti-p14 polyclonal and anti-PLAP monoclonal antibodies and fluorescently tagged
secondary antibodies prior to fixation. c is the merged image of a and b. In
d–f, cells were transfected with authentic p14 and stained using anti-p14
polyclonal antibody and fluorescently tagged secondary antibodies, and
the endogenous ganglioside GM1 was patched and detected using fluorescently conjugated cholera toxin B and anti-cholera toxin antibody. f is
the merged image of d and e. In g–i, cells were transfected with PLAP, and
PLAP and GM1 were patched and detected as described above. i is the
merged image of g and h. Scale bars ⫽ 10 m.
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deficient in microdomains (i.e. the endoplasmic reticulum). In
any event, the AFM results clearly demonstrated that association of p14 with lipid microdomains does not depend on detergent-induced protein-lipid interactions.
Further detergent-based analysis provided insights into
the heterogeneity of p14 association with cell membrane
microdomains. Cell fractionation studies revealed that a significant proportion of p14 resides in detergent-resistant
membrane environments, a typical feature of microdomainassociated proteins. Recent evidence suggests that DRMs may
not capture intact microdomains, but may be composed of the
lipid and/or protein components extracted from a heterogeneous population of distinct membrane microdomains that share
certain detergent solubility properties (43, 54, 60, 64). Our biochemical and morphological studies support the concept of
heterogeneous membrane microdomains that can be differentially extracted by select detergents into DRMs containing
overlapping subsets of microdomains and that p14 associates
with different subsets of these membrane microdomains. First,
chromatographic results indicated that Triton X-100- and
Lubrol WX-resistant membranes extracted from quail fibroblasts were composed of different lipid compositions, with
LRMs relatively more enriched in cholesterol and containing
less phosphatidylcholine compared with TRMs (Fig. 5). Similar
results have been reported for other cell types, although detergent- and cell type-dependent influences on the nature of the
isolated DRMs contribute to differences in the exact lipid formulations of the DRMs (43, 46). Regardless of the actual lipid
composition of different DRMs, the fact that p14 was isolated in
association with two distinct DRM populations indicates that
p14 can associate with different lipid environments. This observation was consistent with our previous demonstration that
purified p14 is functional in liposomes composed of different
lipid formulations (11).
Second, although PLAP and p14 displayed the same detergent solubility properties and sensitivity to cholesterol depletion (Fig. 6), antibody-based co-patching and immunostaining
of both proteins in intact plasma membranes revealed that p14
did not co-cluster with classical lipid-anchored raft markers
(Fig. 7). These results are in accord with the view that plasma
membranes contain distinct membrane microdomains and/or
that these microdomains are highly dynamic structures. Furthermore, although different microdomains may share similar
detergent solubility properties, these results further caution
against directly equating the biochemical and biophysical properties of DRMs with the actual features of membrane microdomains present in intact cell membranes. As noted by others
(21–23, 60), detergent extraction is likely to promote partial
disruption and/or exchange between different membrane
microdomains, making the presence of proteins in the same
DRM fraction a poor prognosticator of their co-localization in
native membranes.
The segregation of certain proteins into DRMs obtained
using different detergents suggests that some microdomains
can be subclassified based on their detergent solubility properties. Such is the case for proteins such as the microvillar protein
prominin-1, the ATP cassette-binding transporter ABCA1, the
small GTPase CDC42, and mature components of the ␥-secreJOURNAL OF BIOLOGICAL CHEMISTRY
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microdomains has important implications for models of p14induced membrane fusion.
As an aside, we have also shown, for the first time, that the
cell-cell fusion activity of VSV-G is unaffected by acute cholesterol depletion, an observation consistent with the designation
of VSV-G as a “non-raft” membrane protein. Cholesterol depletion using the auxotrophic N-BP-2 cells resulted, however, in
substantial inhibition of VSV-G fusion activity. This contrasts
with previous results indicating that VSV-G can induce cell-cell
fusion in other cholesterol-deprived cell types (61). The discrepancies in the cholesterol dependence of VSV-G fusion
activity presumably reflect different pleiotropic effects arising
from the various approaches used to deplete membrane cholesterol (i.e. acute chemical depletion versus extended cholesterol
deprivation in different cell types). These results suggest that, at
least for VSV-G, acute chemical depletion may be a preferred
approach for depleting membrane cholesterol.
Our data also suggest that p14 is an example of a microdomain-associated protein that can be extracted into biochemically distinct DRM environments, one of which is operationally
defined by cholesterol-dependent resistance to extraction with
Lubrol WX; displacement of p14 from these Lubrol WX-resistant membranes coincided with the inhibition of p14-induced
cell fusion. On the basis of these observations, we propose that
p14 localizes to membrane microdomains that exhibit heterogeneity in their biophysical properties and that a subset of these
microdomains may be more relevant to the process of p14induced syncytium formation.
In addition to the standard detergent extraction and cholesterol depletion approaches most commonly employed to define
microdomain-associated proteins, we exploited our recently
developed fusogenic p14-containing liposome system and the
high resolution of AFM to reveal the preferential association of
functional p14 with lipid microdomains under aqueous conditions (Fig. 4). Supported planar lipid bilayers have been
employed under aqueous conditions in conjunction with AFM
to provide important insights into the spontaneous formation
of lipid microdomains and the association of purified proteins
with these microdomains (49 –51, 53, 62, 63). Such was the case
in this study, in which we observed the spontaneous formation
of microdomains with a projection above the lipid bilayer that
closely corresponded with previous estimates on the thickness
of cholesterol- and/or sphingomyelin-enriched lipid microdomains. The clear presence of protein spikes projecting above
these lipid microdomains in p14-containing bilayers indicated
that p14 associates with what are presumably liquid-ordered
microdomains under aqueous conditions.
Although detergent-based analysis indicated that approximately half of the p14 present in transfected cells was not isolated in association with DRMs (Fig. 2C), the AFM results indicated that, when p14 resides in a lipid bilayer that contains
liquid-ordered lipid microdomains, it has a high affinity for
association with such microdomains. The under-representation of p14 association with lipid microdomains following
detergent extraction may reflect either partial detergent extraction from lipid microdomains or trafficking of p14 through the
endoplasmic reticulum-Golgi pathway (4), resulting in the
presence of p14 in cell membranes generally considered to be
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tase complex, all of which selectively associate in specific cell
types with LRMs, but not TRMs (44 – 46). Proteins present in
other microdomains escape subclassification based on differential detergent solubility because, as with p14, they are isolated in
association with both LRMs and TRMs (45, 46, 55). However,
cholesterol depletion helped to identify a subset of microdomain-associated p14 operationally defined by its cholesteroldependent resistance to Lubrol WX extraction, providing a
third line of evidence that p14 associates with different subsets
of membrane microdomains. Cholesterol depletion resulted in
a 50% displacement of p14 from LRMs (Fig. 6) and a coincident
80% inhibition of p14-induced syncytium formation, effects
that were largely reversed by repletion of membrane cholesterol (Fig. 1). In contrast, cholesterol depletion had no significant effect on the association of p14 or PLAP with TRMs. The
differential effects of cholesterol depletion on p14 association
with DRMs also correlated with the increased cholesterol content of the LRMs versus TRMs (Fig. 5). We suggest that LRMs
may capture a subpopulation of cholesterol-dependent
microdomains not represented in the Triton X-100-resistant
membrane fraction. Moreover, the effects of cholesterol depletion on p14-induced syncytium formation further suggested
that the collection of compositionally distinct microdomains
recovered following Lubrol WX extraction might contain a
subpopulation of membrane microdomain-associated p14
more likely to be involved in the cell-cell fusion process.
Insights into the nature of the FAST proteins and the possible roles of microdomain populations present in LRMs provide
a potential explanation for the role of Lubrol WX-resistant,
p14-containing microdomains in the mechanism of p14-induced cell fusion. Microdomain-associated proteins extracted
into LRMs have been implicated in regulating protein trafficking to, or the formation of, plasma membrane protrusions. For
example, prominin-1 (CD133) is a pentaspan membrane protein that selectively localizes to microvilli or plasma membrane
protrusions and that associates exclusively with LRMs, leading
to the proposal that some Lubrol WX-resistant microdomains
regulate protein localization to microvilli (45). Similarly,
ABCA1 and CDC42 are both involved in filopodial formation
and both associate with LRMs, suggesting that Lubrol WXresistant microdomains may be involved in coordinating the
formation of membrane protrusions (46, 65, 66). Based on the
above considerations, it is plausible that p14 may use a subset
of membrane microdomains, defined by their cholesterol-dependent resistance to Lubrol WX extraction, to localize a percentage of p14 to regions of the plasma membrane involved in
close cell-cell contact. In addition to promoting cell-cell contact, such protrusions are likely to exhibit curvature stress and
altered lipid packing. The altered biophysical properties of
membranes in constrained protruding regions of the plasma
membrane (33) may well contribute to lowered energy barriers
for membrane fusion that can be circumvented by the FAST
proteins, without the need for extensive energy input derived
from structural rearrangements of complex metastable ectodomains. We are currently exploring these and other possible
implications of p14 association with distinct subsets of membrane microdomains in the mechanism of p14-induced cell
fusion.
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